Viewing Study NCT00283959


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2025-12-26 @ 1:42 PM
Study NCT ID: NCT00283959
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2006-01-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
Sponsor: Amicus Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FAB-CL-202 (AA1565521)
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators